Active ingredientPentobarbitalCat. No. P-P053-001CAS 76-74-4Family · Pharmaceutical analytical standards
Pentobarbital
A barbiturate developed in 1930 by chemists Ernest Volwiler and Donalee Tabern, used as a sedative, before anaesthesia, to control emergency seizures and to lower intracranial pressure; in veterinary medicine it is used as an anaesthetic. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?The same two chemists synthesised thiopental, a famous intravenous anaesthetic, in 1934, and for this they were inducted into the US National Inventors Hall of Fame in 1986.
Go to the active ingredient →Active ingredientPentobarbitalCat. No. P-P053-001CAS 76-74-4
Active ingredientPentobarbital Sodium SaltCat. No. P-P053-002CAS 57-33-0
Pharmacopoeial impurityPentobarbital EP Impurity ECat. No. P-P053-003CAS 17013-37-5No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substancePentobarbital CRSEDQM code P0500000Family PentobarbitalImpurityPentobarbital impurity E CRSEDQM code Y0002026Family PentobarbitalReference substancePentobarbital sodium CRSEDQM code Y0002194Family PentobarbitalNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.